Brett R. Beno

3.5k total citations · 1 hit paper
56 papers, 2.6k citations indexed

About

Brett R. Beno is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Brett R. Beno has authored 56 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Organic Chemistry, 18 papers in Molecular Biology and 11 papers in Infectious Diseases. Recurrent topics in Brett R. Beno's work include HIV/AIDS drug development and treatment (11 papers), Advanced Chemical Physics Studies (11 papers) and Organic Chemistry Cycloaddition Reactions (8 papers). Brett R. Beno is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), Advanced Chemical Physics Studies (11 papers) and Organic Chemistry Cycloaddition Reactions (8 papers). Brett R. Beno collaborates with scholars based in United States, Germany and India. Brett R. Beno's co-authors include K. N. Houk, Elisheva Goldstein, Nicholas A. Meanwell, Lewis D. Pennington, Kap‐Sun Yeung, Michael D. Bartberger, Daniel A. Singleton, Sarah Wilsey, Kim D. Janda and Richard A. Lerner and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Brett R. Beno

56 papers receiving 2.5k citations

Hit Papers

A Survey of the Role of Noncovalent Sulfur Interactions i... 2015 2026 2018 2022 2015 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design
    2015 620 citations Brett R. Beno, Kap‐Sun Yeung et al. Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brett R. Beno United States 22 1.6k 690 469 373 298 56 2.6k
Jeffrey D. Evanseck United States 27 1.4k 0.9× 860 1.2× 571 1.2× 517 1.4× 447 1.5× 60 2.8k
James F. Blake United States 31 1.5k 0.9× 978 1.4× 514 1.1× 310 0.8× 345 1.2× 57 2.9k
Ferran Feixas Spain 29 1.6k 1.0× 436 0.6× 399 0.9× 445 1.2× 249 0.8× 59 2.6k
Christopher N. Rowley Canada 30 1.7k 1.1× 1.1k 1.6× 648 1.4× 217 0.6× 282 0.9× 70 3.5k
Ödön Farkas Hungary 26 630 0.4× 1.1k 1.5× 453 1.0× 393 1.1× 412 1.4× 64 2.1k
Frank K. Brown United States 23 1.1k 0.7× 1.0k 1.5× 392 0.8× 210 0.6× 237 0.8× 47 2.3k
Jenn‐Huei Lii United States 21 641 0.4× 457 0.7× 607 1.3× 365 1.0× 449 1.5× 51 1.7k
Xavier Fradera Spain 22 1.5k 0.9× 450 0.7× 873 1.9× 924 2.5× 355 1.2× 57 2.8k
Darryl Rideout United States 20 1.6k 1.0× 1.1k 1.6× 178 0.4× 181 0.5× 247 0.8× 29 2.9k
Suyong Re Japan 27 531 0.3× 828 1.2× 688 1.5× 171 0.5× 352 1.2× 61 2.1k

Countries citing papers authored by Brett R. Beno

Since Specialization
Citations

This map shows the geographic impact of Brett R. Beno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett R. Beno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett R. Beno more than expected).

Fields of papers citing papers by Brett R. Beno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett R. Beno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett R. Beno. The network helps show where Brett R. Beno may publish in the future.

Co-authorship network of co-authors of Brett R. Beno

This figure shows the co-authorship network connecting the top 25 collaborators of Brett R. Beno. A scholar is included among the top collaborators of Brett R. Beno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett R. Beno. Brett R. Beno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoon, David, Chunjian Liu, Wei Wang, et al.. (2024). Atropisomerism Observed in Galactose-Based Monosaccharide Inhibitors of Galectin-3 Comprising 2-Methyl-4-phenyl-2,4-dihydro-3H-1,2,4-triazole-3-thione. Journal of Medicinal Chemistry. 67(16). 14184–14199. 3 indexed citations
2.
Swidorski, Jacob J., Brett R. Beno, Chunjian Liu, et al.. (2023). Discovery and exploration of monosaccharide linked dimers of galectin-3 inhibitors to target fibrosis. Medicinal Chemistry Research. 32(7). 1453–1480. 3 indexed citations
3.
Xu, Li, Richard A. Hartz, Brett R. Beno, et al.. (2021). Synthesis, Structure–Activity Relationships, and In Vivo Evaluation of Novel Tetrahydropyran-Based Thiodisaccharide Mimics as Galectin-3 Inhibitors. Journal of Medicinal Chemistry. 64(10). 6634–6655. 18 indexed citations
4.
Zhang, Mengru, Richard Y.‐C. Huang, Brett R. Beno, et al.. (2020). Epitope and Paratope Mapping of PD-1/Nivolumab by Mass Spectrometry-Based Hydrogen–Deuterium Exchange, Cross-linking, and Molecular Docking. Analytical Chemistry. 92(13). 9086–9094. 39 indexed citations
5.
Zhang, Sharon, Neelanjana Ray, Brett R. Beno, et al.. (2019). Resistance profile of the HIV-1 maturation inhibitor GSK3532795 in vitro and in a clinical study. PLoS ONE. 14(10). e0224076–e0224076. 14 indexed citations
6.
Zhang, Mengru, Brett R. Beno, Richard Y.‐C. Huang, et al.. (2019). An Integrated Approach for Determining a Protein–Protein Binding Interface in Solution and an Evaluation of Hydrogen–Deuterium Exchange Kinetics for Adjudicating Candidate Docking Models. Analytical Chemistry. 91(24). 15709–15717. 35 indexed citations
7.
Civiello, Rita L., Xiaojun Han, Brett R. Beno, et al.. (2016). Synthesis and SAR of calcitonin gene-related peptide (CGRP) antagonists containing substituted aryl-piperazines and piperidines. Bioorganic & Medicinal Chemistry Letters. 26(4). 1229–1232. 4 indexed citations
8.
Beno, Brett R., Kap‐Sun Yeung, Michael D. Bartberger, Lewis D. Pennington, & Nicholas A. Meanwell. (2015). A Survey of the Role of Noncovalent Sulfur Interactions in Drug Design. Journal of Medicinal Chemistry. 58(11). 4383–4438. 620 indexed citations breakdown →
9.
Rigat, Karen, Hao Lu, Ying-Kai Wang, et al.. (2014). Mechanism of Inhibition for BMS-791325, a Novel Non-nucleoside Inhibitor of Hepatitis C Virus NS5B Polymerase. Journal of Biological Chemistry. 289(48). 33456–33468. 17 indexed citations
10.
Ding, Min, Feng He, Thomas W. Hudyma, et al.. (2012). Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: Potent allosteric inhibitors of the hepatitis C virus NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 22(8). 2866–2871. 15 indexed citations
11.
Wichroski, Michael, Jie Fang, Betsy J. Eggers, et al.. (2012). High-Throughput Screening and Rapid Inhibitor Triage Using an Infectious Chimeric Hepatitis C Virus. PLoS ONE. 7(8). e42609–e42609. 8 indexed citations
12.
Gentles, Robert G., Min Ding, Xiaofan Zheng, et al.. (2011). SAR studies on a series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides: Potent inhibitors of the polymerase enzyme (NS5B) of the hepatitis C virus. Bioorganic & Medicinal Chemistry Letters. 21(10). 3142–3147. 5 indexed citations
13.
Gentles, Robert G., S. Sheriff, Brett R. Beno, et al.. (2011). Investigation of the mode of binding of a novel series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides to the hepatitis C virus polymerase. Bioorganic & Medicinal Chemistry Letters. 21(8). 2212–2215. 8 indexed citations
14.
Martin, Scott, Peter W. Glunz, Brett R. Beno, et al.. (2011). The Synthesis and evaluation of a novel class of (E)-3-(1-cyclohexyl-1H-pyrazol-3-yl)-2-methylacrylic acid Hepatitis C virus polymerase NS5B inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(10). 2869–2872. 11 indexed citations
15.
Deskus, Jeffrey A., C.P. Sloan, Jingfang Qian‐Cutrone, et al.. (2007). Conformationally restricted homotryptamines 3. Indole tetrahydropyridines and cyclohexenylamines as selective serotonin reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(11). 3099–3104. 38 indexed citations
16.
Potin, Dominique, Eric Nicolaï, F. Caussade, et al.. (2005). De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold. Bioorganic & Medicinal Chemistry Letters. 15(4). 1161–1164. 12 indexed citations
17.
Schnur, Dora M., Brett R. Beno, Andrew C. Good, & Andrew J. Tebben. (2004). Approaches to Target Class Combinatorial Library Design. Methods in molecular biology. 275. 355–377. 11 indexed citations
18.
Beno, Brett R. & Jonathan S. Mason. (2001). The design of combinatorial libraries using properties and 3D pharmacophore fingerprints. Drug Discovery Today. 6(5). 251–258. 27 indexed citations
19.
Mason, Jonathan S. & Brett R. Beno. (2000). Library design using BCUT chemistry-space descriptors and multiple four-point pharmacophore fingerprints: simultaneous optimization and structure-based diversity. Journal of Molecular Graphics and Modelling. 18(4-5). 438–451. 20 indexed citations
20.
Gouverneur, Véronique, K. N. Houk, Beatriz de Pascual‐Teresa, et al.. (1993). Control of the exo and endo Pathways of the Diels-Alder Reaction by Antibody Catalysis. Science. 262(5131). 204–208. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey D. Evanseck Breakdown of academic impact, for papers by James F. Blake Breakdown of academic impact, for papers by Ferran Feixas Breakdown of academic impact, for papers by Christopher N. Rowley Breakdown of academic impact, for papers by Ödön Farkas Breakdown of academic impact, for papers by Frank K. Brown Breakdown of academic impact, for papers by Jenn‐Huei Lii Breakdown of academic impact, for papers by Xavier Fradera Breakdown of academic impact, for papers by Darryl Rideout Breakdown of academic impact, for papers by Suyong Re
Rankless by CCL
2026